Literature DB >> 6173084

Reticulocytosis, hypochromia, and microcytosis: an unusual presentation of the preleukemic syndrome.

M Tulliez, U Testa, H Rochant, A Henri, W Vainchenker, J Touboul, J Breton-Gorius, B Dreyfus.   

Abstract

Two patients exhibiting a highly unusual preleukemic syndrome with marked reticulocytosis, hypochromia, and microcytosis are reported. This red cell phenotype has been investigated by means of HbF, HbA2, and i-antigen activity dosages, immunofluorescence labeling of F cells, reticulocyte survival, globin chain synthesis, and electron microscopy study. The marked reticulocytosis is explained by a delayed disappearance of the reticulum. Serum iron is normal, and a thalassemic syndrome is excluded because of a balanced alpha/non-alpha globin chain synthesis. Electron microscopy studies are consistent with a defect in iron uptake by erythroid cells. All the hematologic data and investigations are similar to those observed for the Belgrade laboratory rat. It is hypothesized that the low expression of HbF and i-Ag associated with microcytosis are related to a prolongation of erythroid maturation as reflected by abnormal reticulocyte survival.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173084

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

Review 2.  Mechanisms of heme iron absorption: current questions and controversies.

Authors:  Adrian-R West; Phillip-S Oates
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

3.  Pseudoreticulocytosis in a patient with myelodysplasia.

Authors:  B Hertenstein; E Kurrle; M Redenbacher; R Arnold; H Heimpel
Journal:  Ann Hematol       Date:  1993-09       Impact factor: 3.673

Review 4.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.